Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Diseases: Page 2
Lipid enzyme blocker renders prostate cancer cells vulnerable to PARP inhibitors in study
By
Nick Paul Taylor
Blocking lipid synthesis enhanced the effect of PARP inhibitors on prostate cancer in a preclinical study, pointing to a potential way to make the treatments effective in more patients.
April 15, 2024
Urine test halves use of invasive procedure to monitor bladder cancer
By
Nick Paul Taylor
A urine test can cut the number of cystoscopies necessary to follow up high-risk bladder cancer patients without increasing the risk of recurrence, a study has found.
April 11, 2024
Researchers tweak TB treatment assay to support global use
By
Nick Paul Taylor
Researchers have developed a tuberculosis (TB) treatment assay that could be a faster, simpler method for monitoring patients.
April 10, 2024
Skin biopsy test shows promise for detection of neurogenerative diseases
By
Matt Limb
A simple skin biopsy test has shown a high accuracy rate in detecting an abnormal form of alpha-synuclein, the pathological hallmark of Parkinson's disease and other synucleinopathies, say neurologists.
April 5, 2024
Researchers map protein biomarkers in sepsis fight
By
Liz Carey
Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.
April 2, 2024
U.K. researchers get funding for lung cancer vaccine development
By
Matt Limb
Researchers are working to develop a lung cancer vaccine in the U.K. with 1.7 million pounds ($2.2 million) funding from leading charities.
April 4, 2024
U.K. team develops new approach to detect signs of motor neuron disease
By
Matt Limb
Scientists have identified a new way to detect signs of motor neuron disease (MND) in brain tissue, raising hopes for early diagnosis and intervention before onset of symptoms.
April 3, 2024
Castle Biosciences shares melanoma test study data at SSO 2024
By
LabPulse.com staff writers
Castle Biosciences shared data from two studies on the performance of its DecisionDx-Melanoma test in patients with cutaneous melanoma at the Society of Surgical Oncology 2024 (SSO 2024) annual meeting, held March 20-23 in Atlanta.
March 26, 2024
Ibex presents new study data for AI-powered cancer diagnostics platform
By
Matt Limb
Ibex Medical Analytics is hailing positive data from studies with U.S. partners on the impact of its artificial intelligence (AI)-powered cancer diagnostic platform Galen.
March 26, 2024
AbbVie to buy Landos Biopharma for up to $212M
By
LabPulse.com staff writers
AbbVie has announced that it will buy drug developer Landos Biopharma in a deal worth up to $212 million. The deal will expand Abbvie’s portfolio, especially in the arena of immune system-related illnesses.
March 25, 2024
Study sheds light on the organization of immune cells in tumors
By
Matt Limb
Researchers have revealed how immune cells are spatially organized within some tumors and that certain immune “hubs” may be linked to better cancer treatment responses.
March 27, 2024
Bio-Techne receives IVDR certification for chronic myeloid leukemia monitoring test
By
LabPulse.com staff writers
Bio-Techne has announced that Asuragen, part of its molecular diagnostics division, has completed class C certification under the new European Union IVDR for its QuantideX qPCR BCR-ABL IS kit for monitoring chronic myeloid leukemia.
March 22, 2024
Previous Page
Page 2 of 284
Next Page